Literature DB >> 17308910

[A 63 year old Turkish woman with recurrent pneumonia].

M Breidert1, R Janssen-Langenstein, S Hambrecht.   

Abstract

The differential diagnosis of a sinubronchial syndrome includes cystic fibrosis, allergic bronchopulmonic aspergillosis, Kartagener's syndrome, hypogammaglobulinemia and bronchioli-associated processes. The latter include cryptogenic organising pneumonia, constrictive bronchiolitis obliterans as well as the respiratory bronchiolitis. Our case presented a persistent interstitial shadow in the x-rax of the thorax and a relevant, mixed ventilation disturbance in lung function. A surgically performed lung biopsy finally allowed the diagnosis of diffuse panbronchiolitis, which is seldom found in central Europe. This disease is of unknown etiology and responds to long-term macrolide therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17308910     DOI: 10.1007/s00108-007-1809-x

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  7 in total

1.  Diffuse panbronchiolitis: a treatable sinobronchial disease in need of recognition in the United States.

Authors:  Padmanabhan Krishnan; Rajeeve Thachil; Virgilio Gillego
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

2.  Microscopic polyangiitis associated with diffuse panbronchiolitis.

Authors:  Jangchul Park; Shogo Banno; Yoshiki Sugiura; Kosho Yoshikawa; Taio Naniwa; Kaori Wakita; Yoshihito Hayami; Shigeki Sato; Ryuzo Ueda
Journal:  Intern Med       Date:  2004-04       Impact factor: 1.271

3.  [Rheumatoid arthritis-associated bronchiolitis successfully treated with erythromycin].

Authors:  S Matsui; N Yamashita; M Narukawa; R Hayashi; Y Yoshida; N Arai; M Maruyama; M Kobayashi; M Kitagawa
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2000-03

4.  Overproduction of MUC5AC core protein in patients with diffuse panbronchiolitis.

Authors:  Yukihiro Kaneko; Katsunori Yanagihara; Yoshitsugu Miyazaki; Yoichi Hirakata; Hiroshi Mukae; Kazunori Tomono; Yoshio Okada; Jun-Ichi Kadota; Shigeru Kohno
Journal:  Respiration       Date:  2003 Sep-Oct       Impact factor: 3.580

Review 5.  Diffuse panbronchiolitis: role of macrolides in therapy.

Authors:  Naoto Keicho; Shoji Kudoh
Journal:  Am J Respir Med       Date:  2002

Review 6.  The effects of macrolides on inflammatory cells.

Authors:  Jun Tamaoki
Journal:  Chest       Date:  2004-02       Impact factor: 9.410

Review 7.  Bronchiolar disorders.

Authors:  Jay H Ryu; Jeffrey L Myers; Stephen J Swensen
Journal:  Am J Respir Crit Care Med       Date:  2003-12-01       Impact factor: 21.405

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.